Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FHLC vs. HGHAX: which is better?

Bottom line

FHLC vs HGHAX: the short answer

FHLC (Fidelity MSCI Health Care Index ETF) and HGHAX (The Hartford Healthcare Fund) share a meaningful slice of their top holdings — about 72% by weight.

But FHLC is far broader, holding 337 positions to 80 for HGHAX, so beyond the top names it adds exposure HGHAX doesn't have.

FHLC is cheaper at 0.084% vs 1.33% — a difference of $125 a year per $10,000 invested.

HGHAX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

FHLC vs HGHAX side by side

FHLCHGHAX
TypeETFMutual fund
Fund familyFidelityHartford
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.084%1.33%
Annual cost per $10k$8.4$133
10-yr cost on $10k (prospectus)$108$2,063
Max front loadNone5.5%
12b-1 fee0%0.25%
1-yr return+2.6%—
5-yr return (annualized)+7.2%—
10-yr return (annualized)+8.8%—
Best quarter+16.4%+20.9%
Worst quarter−13.1%−15.7%
Net assets (fund)$3.3B$772.2M
Number of holdings33780
Portfolio turnover3%49%
Returns as ofNov 30, 2025—

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFHLCHGHAXDifference
2024+2.6%0.0%+2.6%
2023+2.5%+3.8%−1.3%
2022−5.5%−11.7%+6.3%
2021+20.4%+10.0%+10.4%
2020+18.1%+22.6%−4.5%
2019+21.9%+33.3%−11.3%
2018+5.5%−3.0%+8.5%
2017+23.3%+21.6%+1.7%
2016−3.3%−8.6%+5.2%

Source: Fund prospectus bar charts

Holdings overlap

19 of FHLC's top 25 holdings also appear in HGHAX's top 25.

Shared top holdings
HoldingFHLCHGHAX
Eli Lilly & Co13.35%12.03%
Johnson & Johnson8.93%6.75%
AbbVie Inc6.42%4.21%
UnitedHealth Group Inc5.44%4.74%
Merck & Co Inc4.66%6.00%
Thermo Fisher Scientific Inc3.09%1.58%
Amgen Inc3.00%1.39%
Abbott Laboratories2.66%1.82%
CVS Health Corp1.92%2.84%
Intuitive Surgical Inc1.82%2.88%
Danaher Corp1.80%2.57%
Vertex Pharmaceuticals Inc1.76%2.64%
Stryker Corp1.62%1.24%
Medtronic PLC1.59%1.12%
Elevance Health Inc1.19%3.00%

Source: SEC Form N-PORT

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

HGHAX top 10

  1. Eli Lilly & Co — 12.03%
  2. Johnson & Johnson — 6.75%
  3. Merck & Co Inc — 6.00%
  4. UnitedHealth Group Inc — 4.74%
  5. AbbVie Inc — 4.21%
  6. Elevance Health Inc — 3.00%
  7. Intuitive Surgical Inc — 2.88%
  8. CVS Health Corp — 2.84%
  9. Vertex Pharmaceuticals Inc — 2.64%
  10. Danaher Corp — 2.57%

FAQ

What is the difference between FHLC and HGHAX?
FHLC (Fidelity MSCI Health Care Index ETF) and HGHAX (The Hartford Healthcare Fund) share a meaningful slice of their top holdings — about 72% by weight. But FHLC is far broader, holding 337 positions to 80 for HGHAX, so beyond the top names it adds exposure HGHAX doesn't have.
Which is cheaper, FHLC or HGHAX?
FHLC has the lower expense ratio (0.084%).
Should I own both FHLC and HGHAX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.